262 results match your criteria: "Cardinal Massaia Hospital[Affiliation]"
Cancer Treat Rev
April 2024
Division of Nephrology, Dialysis and Renal Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
We are witnessing a revolution in the treatment of metastatic renal cell carcinoma (mRCC). Indeed, several immune-based combinations (ICI [immune checkpoint inhibitor] + ICI, or ICI + antiangiogenic agents) have been approved as first-line therapy for mRCC after demonstrating superior efficacy over the previous standard. Despite all the improvements made, safety remains a critical issue, adverse events (AEs) being the main reason for drug discontinuations or dose reductions, ultimately resulting in an increased risk of losing efficacy.
View Article and Find Full Text PDFPathologica
February 2024
Medical and Translational Oncology, Department of Oncology, Azienda Ospedaliera S. Maria, Terni, Italy.
Tumori
June 2024
Medical Oncology Unit, Ospedale di Summa A. Perrino, Brindisi, Italy.
Purpose: Cancer treatment-induced bone loss is a side effect of hormonal therapy that can severely affect patients' quality of life. The aim of this survey was to obtain an updated picture of management of bone health in patients with breast cancer undergoing adjuvant hormonal therapy and in patients with hormone sensitive prostate cancer according to Italian oncologists.
Methods: Our survey was made up of 21 multiple-choice questions: the first part dealt with the respondents' characteristics, while the second with management of bone health in the described setting.
Neurol Ther
June 2024
Department of Medicine and Surgery, Headache Center, Neurology Unit, University of Parma, Parma, Italy.
Support Care Cancer
March 2024
Medical Oncology Unit, Ospedale Di Summa A. Perrino, Brindisi, Italy.
Purpose: Optimal use of bone-modifying agents (BMAs) in patients with bone metastases from solid tumors is uncertain in some aspects: the drug choice; the planned treatment duration and long-term therapy; the prevention and management of possible side effects, including renal toxicity, hypocalcaemia, and medication-related osteonecrosis of the jaw (MRONJ).
Methods: Italian oncologists were invited to fulfil a 24-question web survey about prescription of BMAs for bone metastases of breast cancer, prostate cancer, and other solid tumors. Prevention and management of side effects were also investigated.
Intractable Rare Dis Res
February 2024
Department of Surgical Sciences, Policlinico Umberto I University Hospital, Sapienza University of Rome, Rome, Italy.
Situs viscerum inversus (SVI) is a very rare condition in that abdominal and thoracic organs are located reversed. Abdominal aortic aneurysm (AAA) is a life-threatening pathology due to progressive aortic enlargement until the rupture. The association between SVI and AAA is very infrequent.
View Article and Find Full Text PDFMinerva Anestesiol
March 2024
Department of Surgical Sciences, University of Turin, Turin, Italy -
J Clin Med
January 2024
Department of Medical Oncology, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Italy.
The use of immune checkpoint inhibitors (ICIs) in combination with tyrosine kinase inhibitors or other ICIs has significantly improved the prognosis for patients with mccRCC. This marks a major milestone in the treatment of mccRCC. Nonetheless, most patients will discontinue first-line therapy.
View Article and Find Full Text PDFInt J Mol Sci
December 2023
Department of Oncology, University of Turin, AOU San Luigi Gonzaga, 10043 Orbassano, Italy.
Androgen receptor pathway inhibitors (ARPI) and polyadenosine diphosphate-ribose inhibitors (PARPi) are part of the standard of care in patients with metastatic castration-resistant prostate cancer (mCRPC). There is biological evidence that the association of ARPI and PARPi could have a synergistic effect; therefore, several ongoing clinical trials are investigating the efficacy of this combination with preliminary results that are not perfectly concordant in identifying patients who can obtain the most benefit from this therapeutic option. The purpose of this review is to describe the PARPi mechanisms of action and to analyze the biological mechanisms behind the interplay between the androgen receptor and the PARPi system to better understand the rationale of the ARPI + PARPi combinations.
View Article and Find Full Text PDFJ Cardiovasc Echogr
November 2023
Cardiology Division, University Hospital Polyclinic G. Martino, University of Messina, Messina, Italy.
Antibiotics (Basel)
December 2023
Microbiology and Virology Unit, University Hospital City of Health and Science of Turin, 10126 Turin, Italy.
Prostate Cancer Prostatic Dis
September 2024
Istituto Oncologico della Svizzera Italiana, EOC, Bellinzona, Switzerland.
Spinal Cord
January 2024
Department of Public Health and Paediatric Sciences, University of Turin, Turin, Italy.
Study Design: Qualitative descriptive.
Objectives: To describe the experiences of people with Spinal Cord Injury (SCI) re-admitted to the hospital due to continence-related complications.
Setting: Inpatient service of a large spinal unit in North-West of Italy.
HeartRhythm Case Rep
October 2023
Division of Cardiology, Cardinal Massaia Hospital, Asti, Italy.
Diagnostics (Basel)
October 2023
Pediatric Cardiology and GUCH Unit, Fondazione "G. Monasterio" CNR-Regione Toscana, 541200 Massa, Italy.
Managing repaired tetralogy of Fallot (TOF) patients is still challenging despite the fact that published studies identified prognostic clinical or imaging data with rather good negative predictive accuracy but weak positive predictive accuracy. Heterogeneity of the initial anatomy, the surgical approach, and the complexity of the mechanism leading to dilation and ventricular dysfunction explain the challenge of predicting the adverse event in this population. Therefore, risk stratification and management of this population remain poorly standardized.
View Article and Find Full Text PDFClin Cancer Res
March 2024
Department of Experimental Oncology, S.S.D. Nutrition Research and Metabolomics, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Purpose: The DIANA-5 randomized controlled trial assessed the effectiveness of a diet based on Mediterranean and macrobiotic traditions (macro-Mediterranean diet) in reducing breast cancer recurrence.
Patients And Methods: The DIANA-5 study involved 1,542 patients with breast cancer at high risk of recurrence because of estrogen receptor-negative cancer, or metabolic syndrome, or high plasma levels of insulin or testosterone. Women were randomly assigned to an active dietary intervention (IG) or a control group (CG).
J Infect Dev Ctries
September 2023
Cardinal Massaia Hospital, Infectious Diseases, Asti, Italy.
Clin Genitourin Cancer
April 2024
Department of Oncology, San Luigi Gonzaga University Hospital, University of Turin, Orbassano, Italy.
Background: Treatment of metastatic hormone-sensitive prostate cancer (mHSPC) dramatically changed. PEACE-1 and ARASENS trials established triplet therapy efficacy. Identifying prognostic factors supporting treatment choice is pivotal.
View Article and Find Full Text PDFAntibiotics (Basel)
September 2023
Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, "Amedeo di Savoia" Hospital, ASL "Città di Torino", 10060 Turin, Italy.
Ann Card Anaesth
November 2023
Department of Surgery, Valencia University Medical School, Blasco Ibáñez Av; Department of Anesthesia Critical Care and Pain Management, Valencia University General Hospital, Tres Creus Avenue, Valencia, Spain.
Infez Med
September 2023
Department of Medical Sciences, Infectious Diseases, University of Turin, Turin, Italy.
We report the case of a 58-year-old male with a recent diagnosis of HIV infection admitted for progressive muscular weakness and psychomotor impairment. Cerebrospinal examination documented a mild hyperproteinorrachia, with normal cells count and reduced glycorrhachia. Brain gadolinium-enhanced MRI showed bilateral T2 and FLAIR hyperintensities in the nucleo-capsular region and irregular contrast-enhancement of the and the right putamen.
View Article and Find Full Text PDFMinerva Anestesiol
November 2023
Department of Medical Area, University of Udine, Udine, Italy.
Front Cardiovasc Med
July 2023
Department of Cardiac Electrophysiology and Arrhythmology, Clinica Montevergine, Mercogliano, Italy.
Background: Highly localized impedance (LI) measurements during atrial fibrillation (AF) ablation have the potential to act as a reliable predictor of the durability of the lesions created.
Objective: We aimed to collect data on the procedural parameters affecting LI-guided ablation in a large multicenter registry.
Methods: A total of 212 consecutive patients enrolled in the CHARISMA registry and undergoing their first pulmonary vein (PV) isolation for paroxysmal and persistent AF were included.
J Cardiovasc Echogr
May 2023
Cardiology Division, University Hospital Polyclinic G.Martino, University of Messina, Messina, Italy.
Background: The Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI) conducted a national survey to understand better how different echocardiographic modalities are used and accessed in Italy.
Methods: We analyzed echocardiography laboratory activities over a month (November 2022). Data were retrieved via an electronic survey based on a structured questionnaire, uploaded on the SIECVI website.
Microorganisms
April 2023
Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy.
Background: Evidence has shown that short courses of antibiotic therapy are at least as effective as long courses with better clinical outcomes. CAZ/AVI has demonstrated its clinical efficacy in treating -KPC infections.
Methods: We conducted an analysis based on the real-life data of our ten years retrospective cohort to assess the cost-effectiveness and cost-utility of a short course of CAZ/AVI plus source control compared to a long course plus source control.